Determinants of lung cancer evolution: immune escape and inflammation

S. Janes (London, United Kingdom)

Source: International Congress 2018 – Scientific Year in Review
Session: Scientific Year in Review
Session type: Year in review
Number: 3753
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Janes (London, United Kingdom). Determinants of lung cancer evolution: immune escape and inflammation. International Congress 2018 – Scientific Year in Review

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From ineffective tumor immune response to immunomodulation in lung cancer
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017


Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



Immunology and defence mechanism of the developing lung
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60
Year: 2006

The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015



Ageing of the immune system: a contribution to lung disease?
Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung
Year: 2012

Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Immune system dysregulation in chronic lung disease
Source: Eur Respir J 2011; 38: 500-501
Year: 2011


How to define the immune status of lung cancer patient
Source: International Congress 2015 – Stop immune tolerance in lung cancer!
Year: 2015



Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013


Innate and adaptive immune response in lung diseases
Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases
Year: 2019


The estimation of adaptation of functional systems of the patients with a lung cancer and secondary inflammatory changes
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006

Late Breaking Abstract - Human lung microbiota-driven differential innate immune landscape
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021


How infections can modify lung immunity
Source: Eur Respir J 2001; 18: 442-443
Year: 2001


How infections can modify lung immunity
Source: Guideline 2001
Year: 2001